1. Investigating blood cells' chromosomal conformation patterns as new diagnostic markers for prostate cancer. (July 2016) Authors: Pchejetski, D.; Alshaker, H.; Winkler, M.; Akoulitchev, A. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MTOR inhibition overcomes docetaxel chemoresistance in prostate cancer cell and mouse models through downregulation of sphingosine kinase 1. (July 2016) Authors: Alshaker, H.; Wang, Q.; Cooper, C.; Winkler, M.; Pchejetski, D. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Spontaneous antibodies against Engrailed‐2 (EN2) protein in patients with prostate cancer. (August 2014) Authors: Annels, N. E.; Simpson, G. R.; Denyer, M.; McGrath, S. E.; Falgari, G.; Killick, E.; Eeles, R.; Stebbing, J.; Pchejetski, D.; Cutress, R.; Murray, N.; Michael, A.; Pandha, H. Journal: Clinical and experimental immunology Issue: Volume 177:Number 2(2014:Aug.) Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗